Affiliate Disclosure
We earn affiliate commissions when you sign up through our links. This guide compares actual provider pricing to help you make informed budget decisions. See our full disclosure for details.
The Bottom Line: Cost Comparison At a Glance
| Option | Semaglutide | Tirzepatide | Difference |
|---|---|---|---|
| Brand-Name (no insurance) | $968-1,349/mo (Wegovy/Ozempic) | $1,023-1,060/mo (Mounjaro/Zepbound) | ~$100/mo more |
| Compounded (Coreage RX) | $79-299/mo | $249-399/mo | $100-170/mo more |
| Compounded (Hims & Hers) | $79-299/mo | $199-399/mo | $100-120/mo more |
| Annual Cost (compounded) | $2,138-3,138/yr (Coreage escalation) | $4,188/yr (Coreage escalation) | $1,050-2,050/yr more |
* Prices as of January 2026 at maintenance doses. Starting doses are cheaper for both medications.
Why Tirzepatide Costs More Everywhere
Tirzepatide is consistently more expensive than semaglutide across all sources—brand-name and compounded. The price premium reflects:
- More complex manufacturing: Dual GIP/GLP-1 receptor agonist is chemically more complex than semaglutide's single GLP-1 mechanism
- Higher API costs: Active pharmaceutical ingredient (tirzepatide peptide) is more expensive to synthesize
- Superior efficacy: 20.9% average weight loss (SURMOUNT-1) vs 14.9% (STEP 1) justifies premium pricing
- Newer to market: Mounjaro/Zepbound launched 2022-2023 vs Ozempic/Wegovy 2017-2021, less price competition
- Compounding complexity: Even for compounding pharmacies, tirzepatide requires more sophisticated quality control
Cost vs Efficacy Trade-Off
Brand-Name Pricing: Tirzepatide vs Semaglutide
Tirzepatide Brand-Name Options
| Medication | Indication | Monthly Cost | Annual Cost |
|---|---|---|---|
| Mounjaro | Type 2 diabetes | $1,023 | $12,276 |
| Zepbound | Weight management | $1,060 | $12,720 |
Semaglutide Brand-Name Options
| Medication | Indication | Monthly Cost | Annual Cost |
|---|---|---|---|
| Ozempic | Type 2 diabetes | $968 | $11,616 |
| Wegovy | Weight management | $1,349 | $16,188 |
Brand-name comparison: Tirzepatide (Mounjaro/Zepbound) costs $55-289/month LESS than Wegovy but $37-92/month MORE than Ozempic. Both are prohibitively expensive without insurance.
Compounded Pricing: Provider-by-Provider Comparison
Compounded versions offer 70-90% savings over brand-name. Here's how tirzepatide and semaglutide pricing compares across major telehealth providers:
Coreage RX: Premium Quality Option
Coreage RX Pricing by Dose
Monthly difference: $100-170 more depending on dose tier
Hims & Hers: Budget-Friendly Option
Hims & Hers Pricing by Dose
Monthly difference: $100-150 more depending on dose tier
Ro: Premium Program with Coaching
Ro Weight Loss Program Pricing
Both include comprehensive coaching program (premium pricing reflects this)
Insurance Coverage: Tirzepatide vs Semaglutide
Insurance coverage differs significantly between these medications based on indication:
Semaglutide Coverage
- ✓ Widely covered for type 2 diabetes
- ✓ Often tier 3 (specialty) with prior auth
- ✓ Copay: $25-150/mo with savings card
- ✗ Off-label weight loss usually denied
- ✗ Most plans exclude weight loss meds
- ~ Some employer plans cover (rare)
- ~ Medicare doesn't cover (as of 2026)
- ~ Savings card helps IF covered (big if)
Tirzepatide Coverage
- ✓ Covered for type 2 diabetes
- ✓ Tier 3-4 with prior authorization
- ✓ Copay: $25/mo with savings card
- ✗ Off-label weight loss usually denied
- ✗ Most plans exclude weight loss meds
- ~ Slightly better coverage than Wegovy (newer)
- ~ Some employer plans cover
- ~ Savings card available IF covered
Coverage reality: For weight loss specifically, neither medication is well-covered by insurance. Both face similar denials. If you have diabetes + obesity, Mounjaro and Ozempic have comparable coverage—tirzepatide doesn't have an advantage here.
Important: Compounded versions are NEVER covered by insurance, regardless of indication.
Long-Term Cost Analysis: 1-Year, 2-Year, 3-Year Projections
GLP-1 treatment is typically long-term (12+ months to reach goals, potentially indefinite maintenance). Here's how costs accumulate:
Scenario 1: Compounded Semaglutide (Coreage RX)
Scenario 2: Compounded Tirzepatide (Coreage RX)
3-Year Cost Difference:
Which Medication Fits Your Budget? Decision Framework
Cost-Based Decision Guide
- ✓Budget is primary concern: Save $1,200-2,000/year vs tirzepatide
- ✓Testing GLP-1s for first time: Lower cost to see if they work for you
- ✓14-15% weight loss sufficient: STEP trials showed excellent results
- ✓Long-term maintenance expected: $3,588/year ongoing is more sustainable
- ✓Insurance covers Ozempic: If you have diabetes, leverage coverage
- ✓Maximizing weight loss is priority: 20.9% average (40% better than semaglutide)
- ✓Semaglutide was insufficient: Tried it, need stronger medication
- ✓Can afford $350-400/month: Budget allows for premium medication
- ✓Significant weight to lose (80+ lbs): Superior efficacy matters more
- ✓Insurance covers Mounjaro: If you have diabetes, coverage may equalize costs
Cost-Saving Strategies for Both Medications
1. Use FSA/HSA Pre-Tax Dollars
Both semaglutide and tirzepatide are prescription medications eligible for FSA/HSA reimbursement. Effective 25-30% savings using pre-tax money.
- Semaglutide annual savings: $2,138 × 25% = ~$535/year saved
- Tirzepatide annual savings: $4,188 × 25% = ~$1,047/year saved
2. Don't Auto-Escalate to Maximum Dose
Many people achieve excellent results at mid-range doses. Work with your physician to find minimum effective dose.
- Semaglutide: Staying at 1.7mg vs 2.4mg saves ~$600/year (Coreage RX)
- Tirzepatide: Staying at 10mg vs 15mg saves $300/year (Coreage RX)
3. Compare Provider Pricing Carefully
Provider differences can be $400-1,000/year. For long-term treatment, this matters:
- Semaglutide: Coreage ($2,138/yr) vs Hims ($2,538/yr) = $400 difference
- Tirzepatide: Hims ($3,788/yr) vs Coreage ($4,188/yr) = $400 savings with Hims
Quality consideration: Coreage RX uses exclusively 503B facilities with third-party testing. Hims uses mixed 503A/503B. For complex tirzepatide, verified quality may be worth $400/year premium.
4. Leverage Insurance for Diabetes Indication
If you have type 2 diabetes + obesity:
- Get Ozempic or Mounjaro prescribed for diabetes (covered)
- Use manufacturer savings card: often $25/month copay
- Annual cost: $300 vs $2,138-4,188 compounded (saves $1,838-3,888/year)
Important: This only works with diabetes diagnosis and commercial insurance. Medicare/Medicaid patients cannot use manufacturer coupons.
Common Questions: Cost Comparison
Is tirzepatide worth the extra $2,000/year vs semaglutide?
Depends on your budget and weight loss goals:
- If budget-conscious: Semaglutide delivers excellent results (14.9% weight loss) at half the cost
- If maximizing results: Tirzepatide's 40% superior efficacy (20.9% vs 14.9%) may justify cost
- Smart approach: Start with semaglutide. Upgrade to tirzepatide if results plateau.
Why is compounded tirzepatide still so expensive?
Even compounded tirzepatide costs $249-399/month because:
- Tirzepatide API (raw material) is 2-3x more expensive than semaglutide
- More complex dual-agonist mechanism requires sophisticated compounding
- Quality control and sterility testing cost more for complex peptides
- Market pricing reflects superior efficacy—providers know patients value results
Can I switch between semaglutide and tirzepatide?
Yes, with physician guidance. Common scenarios:
- Semaglutide → Tirzepatide: If weight loss plateaus, upgrade to stronger medication
- Tirzepatide → Semaglutide: Less common, but possible for cost reasons or side effect management
Your doctor will determine equivalent dosing when switching. There's no "waste" switching—you're optimizing for results and budget.
Which has better insurance coverage for weight loss?
Neither has good coverage for weight loss alone. Both Wegovy and Zepbound face similar denials from most insurance plans. Coverage is marginally better for:
- Employer-sponsored plans that specifically include weight loss medications (rare, ~15% of plans)
- Patients with BMI 40+ and obesity-related comorbidities (sleep apnea, hypertension, etc.)
For diabetes indication (Ozempic/Mounjaro), both have comparable coverage rates—neither has significant advantage.
Our Recommendation: Best Value for Cost-Conscious Patients
Best Budget Strategy: Start with Semaglutide
For most people, starting with compounded semaglutide from Coreage RX offers the best value:
- ✓ Half the cost ($2,138/yr vs $4,188)
- ✓ Proven efficacy (14.9% average weight loss)
- ✓ Test GLP-1 response at lower price point
- ✓ Most people achieve excellent results
- • After 3-6 months if results plateau
- • If weight loss is insufficient for goals
- • If you have significant weight to lose (80+ lbs)
- • If budget allows for premium medication
Evaluate results: If excellent, continue semaglutide. If insufficient, upgrade.
Potential savings: $1,200-2,000/year if semaglutide works well for you
Medical Disclaimer
This article provides cost comparison information for educational purposes. It is not medical advice, financial advice, or insurance guidance. Medication choice should be based on medical appropriateness, not just cost—consult your physician. Pricing data is current as of January 2026 and subject to change. Insurance coverage varies by plan and individual circumstances. Compounded medications are not FDA-approved. We earn affiliate commissions from some providers mentioned in this comparison.
Transparent Pricing Matters
GLP-1 medications are long-term commitments—often 12-24+ months of treatment. Understanding total cost over time helps you make sustainable decisions. We've researched provider pricing across 15+ telehealth companies to give you accurate cost comparisons. Whether you choose semaglutide or tirzepatide, compounded or brand-name, knowing the real numbers lets you budget appropriately and avoid financial surprises mid-treatment.